Rice and MD Anderson collaborative harnesses engineering expertise for cancer solutions

FHS
June 27, 2024
6:12 pm

Led by Rice’s Gang Bao and MD Anderson’s Dr. Jeffrey Molldrem, the initiative aims to foster collaboration between the two institutions on fundamental and translational cancer research, to develop new technologies for cancer detection and therapy and to secure external funding in support of further research and training.

Penn researchers aim to uncover the underlying biological mechanisms of TBI-related neurodegeneration

A team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over

June 28, 2024

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal body weight,”

July 23, 2024

Abeona’s new Form 483 is another manufacturing setback for its rare skin condition asset

Abeona Therapeutics was handed a Form 483 “related to process controls” for its epidermolysis bullosa candidate in a second manufacturing-related roadblock for the program, with

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.